Search For "viatris"
Viatris Certified as a Great Place to Work in India for the Fourth Consecu
Updated : 1 year, 1 month ago IST
Bangalore (Karnataka) [India], April 2: Mylan Laboratories Limited (a Viatris Company) has been recognized with the Great Place to Work® Certification™ in India for the fourth consecutive year. This recognition highlights Viatris' unwavering commitment to fostering a culture of in
Read More
Viatris Certified as a Great Place to Work in India for the Third Consecut
Updated : 2 years, 3 months ago IST
Telangana (Hyderabad) [India], February 19: Mylan Laboratories Limited (a Viatris Company) has been recognized with the prestigious Great Place to Work® CertificationTM in India for the third consecutive time. This recognition is a testament to Viatris' commitment to fostering a posit
Read More
IQuest Enterprises acquires Viatris’ Indian API operations
Updated : 2 years, 8 months ago IST
Hyderabad (Telangana) [India], October 2: IQuest Enterprises has entered into a definitive agreement to acquire the API operations of global pharmaceutical major Viatris in India. IQuest emerged as the preferred investor following a global competitive bid.
Read More
Incture hosted its inaugural Digital Innovation Day with Customers, SAP, a
Updated : 2 years, 8 months ago IST
Bengaluru (Karnataka) [India], September 4: Incture, a leading provider of enterprise digital applications and solutions, hosted its inaugural Digital Innovation Day at its HQ in Bengaluru on 30th August, 2023. The event brought together SAP, industry thought leaders, its customers, and tech
Read More
Biocon Biologics completes acquisition of Viatris' Global Biosimilars Busi
Updated : 3 years, 6 months ago IST
Bengaluru (Karnataka) [India], November 30 (ANI/PRNewswire): Biocon Biologics Ltd., a subsidiary of Biocon Ltd. (BSE code: 532523) (NSE: BIOCON), announced today that it has successfully completed its multi-billion-dollar (USD) acquisition of the global biosimilars business of its partner Vi
Read More
Biocon subsidiary completes acquisition of Viatris for USD 3 billion
Updated : 3 years, 6 months ago IST
According to a statement by the pharma company, Biocon Biologics and Viatris have obtained all applicable approvals from key global regulators including the US Federal Trade Commission, the Competition Commission of India and the Reserve Bank of India, and its investors, respectively.
Read More
Biocon Biologics to acquire Viatris' Biosimilars Assets for up to USD 3.33
Updated : 4 years, 3 months ago IST
Bengaluru (Karnataka) [India], March 1 (ANI/PR Newswire): Biocon Biologics Ltd, a subsidiary of Biocon Ltd (BSE code: 532523) (NSE: BIOCON), has entered into a definitive agreement with its partner Viatris Inc. (NASDAQ: VTRS). Accordingly, Biocon Biologics Ltd (BBL) will acquire Viatris'
Read More